Ki Seong Ko

Title: Ki Seong Ko: Innovator in Pharmaceutical Composition

Introduction

Ki Seong Ko is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of pharmacologically active substances through advanced formulations.

Latest Patents

Ki Seong Ko holds a patent for a "Sustained-release lipid pre-concentrate of GnRH analogues and pharmaceutical composition comprising the same." This invention discloses a pharmaceutical composition that includes at least one sorbitan unsaturated fatty acid ester with multiple hydroxyl groups, a phospholipid, a liquid crystal hardener, and a GnRH analogue. The composition is designed to enhance the sustained release of the GnRH analogue, providing a more effective therapeutic option.

Career Highlights

Ki Seong Ko is currently associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation and delivery systems has positioned him as a key player in the industry.

Collaborations

Some of his notable coworkers include Sang Phil Yoon and Ha Na Yu, who contribute to the collaborative efforts in research and development at Chong Kun Dang Pharmaceutical Corporation.

Conclusion

Ki Seong Ko's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patent reflects a significant advancement in the field, showcasing the potential for enhanced therapeutic outcomes.